Delivery Order SPE2DB24D2010-SPE2DB25FZZF0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,133.96 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count packages), with an ultimate completion date of August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical SPE2DX prime vendor contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $30,399.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) at a firm fixed price of $6,127.65, with an ultimate completion date of November 19, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The award is issued as a delivery order under the company's existing Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract valued at $24,848.80, with an ultimate completion date of September 12, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) valued at $16,636.35 under a firm fixed-price contract. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery of this pharmaceutical product from its corporate office...
- The Defense Logistics Agency awarded a $15,030.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 25, 2025. This award, issued on August 22, 2025, represents a non-set-aside competitive procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,082.81 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FZZF0Delivery Order
The Defense Logistics Agency awarded a $49,905.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count packages of Eliquis 5 mg tablets, with an ultimate completion date of June 3, 2025. This non-competitive delivery order was issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive portfolio of brand-name and generic medications to military and veteran healthcare systems. This delivery order represents a routine pharmaceutical supply transaction under AmerisourceBergen's existing prime contract vehicle with DLA, which enables the company to fulfill medical supply needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. Eliquis, an anticoagulant medication, is a standard pharmaceutical product commonly procured through federal medical supply chains. The award reflects AmerisourceBergen's established role as a primary pharmaceutical vendor within the DLA's medical supply distribution network and its capability to meet firm fixed-price delivery requirements for both routine and specialized pharmaceutical commodities supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.9k | 6/2/25 |